Liu, R., Ji, Z., Wang, X., Zhu, L., Xin, J., Ma, L., Zhang, J., Ge, S., Zhang, L., Yang, Y., Ning, T., Bai, M., Duan, J., Wang, F., Sun, Y., Li, H., Deng, T., Ba, Y., Hao, J. (2025). Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial. Nature Communications. https://doi.org/10.1038/s41467-025-56748-3